Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Hemic or immune system
Reexamination Certificate
2007-12-04
2007-12-04
Belyavskyi, Michail (Department: 1644)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Hemic or immune system
C424S900000, C424S537000, C435S372000, C435S383000
Reexamination Certificate
active
11055292
ABSTRACT:
There is provided an isolated pluri-differentiated human mesenchymal progenitor cells (MPCs), a method for isolating and purifying human mesenchymal progenitor cells from Dexter-type cultures, and characterization of and uses, particularly therapeutic uses for such cells. Specifically, there is provided isolated MPCs which can be used for diagnostic purposes, to enhance the engraftment of hematopoietic progenitor cells, enhance bone marrow transplantation, or aid in the treatment or prevention of graft versus host disease.
REFERENCES:
patent: 5226914 (1993-07-01), Caplan et al.
patent: 5486359 (1996-01-01), Caplan et al.
patent: 5521067 (1996-05-01), Seshi
patent: 5733542 (1998-03-01), Haynesworth et al.
patent: 5811094 (1998-09-01), Caplan et al.
patent: 5879940 (1999-03-01), Torok-Storb et al.
patent: 5942225 (1999-08-01), Bruder et al.
patent: 6010696 (2000-01-01), Caplan et al.
patent: 6149902 (2000-11-01), Artavanis-Tsakonas et al.
patent: 2003/0203483 (2003-10-01), Seshi
patent: 2005/0059147 (2005-03-01), Seshi
patent: WO 01/94541 (2001-12-01), None
patent: WO 03/029432 (2003-04-01), None
Chakrabarti, O. and S. Krishna “Molecular interactions of ‘high risk’ human papillomaviruses E6 and E7 oncoproteins: implications for tumour progession”J. Biosci., 2003, 28(3):337-348.
Charbord, P. et al. “Stromal cells from human long-term marrow cultures, but not cultured marrow fibroblasts, phagocytose horse serum constituents: studies with a monoclonal antibody that reacts with a species-specific epitope common to multiple horse serum proteins”Exp. Hematol., 1987, 15:72-77.
Conget, P.A. and J.J. Minguell “Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells”J. Cell. Physiol., Oct. 1999, 181:67-73.
Dennis, J.E. et al. “A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse”J. Bone and Mineral Res., 1999, 14(5):700-709.
Deunsing, S. and K. Munger “The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability”Cancer Res., 2002, 62:7075-7082.
Deunsing, S. et al. “The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle”PNAS, 2000, 97(18):10002-10007.
Dorshkind, K. “Multilineage development from adult bone marrow cells”Nature Immunology, 2002, 3(4):311-313.
Durst, M. et al. “Inverse relationship between human papilomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines”J. Virology, 1991, 65(2):796-804.
Friedenstein, A.J. et al. “Fibroblast precursors in normal and irradiated mouse hematopoietic organs”Exp. Hemat., 1976, 4:267-274.
Eaves, A.C. and C.J. Eaves “Maintenance and proliferation control of primitive hemopoietic progenitors in long-term cultures of human marrow cells”Blood Cells, 1988, 14:355-368.
Gerson; S.L. “Mesenchymal stem cells: No longer second class marrow citizens”Nature Med., 1999, 5(3):262-264.
Graf, L. et al. “Gene expression profiling of the functionally distinct human bone marrow stromal cell lines HS-5 and HS-27a” Blood, 2002, 100(4):1509-1511.
Gravitt, P. “HPV: The ultimate cancer initiator?”HPV Today, No. 3, Sep. 2003, pp. 1-4.
Haynesworth, S.E. et al. “Characterization of cells with osteogenic potential from human marrow”Bone, 1992, 13:81-88.
Haynesworth, S.E. et al. “Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies”Bone, 1992, 13:69-80.
Henderson, A.J. et al. “Functional characterization of two stromal cell lines that support B lymphopoiesis”J Immunology, 1990, 145:423-428.
Hicok, K.C. et al. “Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma”J. Bone and Mineral Res., 1998, 13(2):205-217.
Horwitz, E.M. et al. “Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta”Nature Med., 1999, 5(3):309-313.
Iwata, M. et al. “Functional interleukin-7 receptors (IL7R) are expressed by marrow stromal cells: binding of IL-7 increases levels of IL-6 mRNA and secreted protein” Aug. 2002 (epub date May 2002), 100:1318-1325.
Keating, A. et al. “Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man”Nature, 1982, 298:280-283.
Kelly, K.A. and J.M. Gimble “1,25-Dihydroxy vitamin D3inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures”Endocrinology, 1998, 139:2622-2628.
Koc, O.N. et al. “Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases”Exp. Hematology, 1999, 27:1675-1681.
Kopen, G.C. et al. “Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains”Proc. Natl. Acad. Sci. USA, 1999, 96:10711-10716.
Liesveld, J.L. et al. “Characterization of human marrow stromal cells: Role in progenitor cell binding and granulopoiesi”Blood, 1989, 73(7):1794-1800.
Moore, M.A.S. et al. “Prolonged hematopoiesis in a primate bone marrow culture system: Characteristics of stem cell production and the hematopoietic microenvironment”Blood, 1979, 54(4):775-793.
Park, S.R. et al. “Interconversion potential of cloned human marrow adipocytes in vitro”Bone, 1999, 24(6):549-554.
Penn, P.E. et al. “Dissecting the hematopoietic microenvironment. IX. Further characterization of murine bone marrow stromal cells”Blood, 1993, 81(5):1205-1213.
Pessina, A. et al. “Expression of B cell markers on SR-4987 cells derived from murine bone marrow stroma”Exp. Hematology, 1997, 25:536-541.
Prockop, D.J. “Marrow stromal cells as stem cells for nonhematopoietic tissues”Science, 1997, 276:71-74.
Roecklein, B.A. and B. Torok-Storb “Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes”Blood, 1995, 85(4):997-1005.
Seshi, B. et al. “Multilineage gene expression in human bone marrow stromal cells as evidenced by single-cell microarray analysis”Blood Cells, Molecules, and Diseases, 2003, 31:268-285.
Siler, U. et al. “Laminin γ2 chain as a stromal cell marker of the human bone marrow microenvironment”Brit. J. Haematology, 2002, 119:212-220.
Simmons, P.J. et al. “Host origin of marrow stromal cells following allogeneic bone marrow transplantation”Nature, 1987, 328:429-432.
Singer, J.W. et al. “Evidence for a stem cell common to hematopoiesis and its in vitro microenvironment: Studies of patients with clonal hematopoietic neoplasia”Leukemia Res., 1985, 8(4):535-545.
Stedman, T.L., Stedman's Medical Dictionary, 5thEdition, 1984, pp. 931-932.
Stoppler, H. et al. “The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length”J. Biol. Chem., 1997, 272(20):13332-13337.
Taichman, R.S. et al. “Human osteoblasts support human hematopoietic progenitor cells in in vitro bone marrow cultures”Blood, 1996, 87(2):518-524.
Torok-Storb, B., ATCC Catalog, ATCC No. CRL-2496.
Torok-Storb, B. et al. “Dissecting the marrow microenvironment”Ann. NY Acad. Sci., 1999, 872:164-170.
Taichman, R.S. and S.G. Emerson “Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimul
Belyavskyi Michail
Saliwanchik Lloyd & Saliwanchik
University of South Florida
LandOfFree
Method for purifying pluri-differentiated mesenchymal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for purifying pluri-differentiated mesenchymal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for purifying pluri-differentiated mesenchymal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3894257